Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026

June 1, 2026 4:15 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that it will be participating in a Fireside Q&A hosted by Lake Street Capital Markets at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub on Wednesday, June 17, 2026, at 10:30 a.m....

Read more

From Elite Athletes to Everyday Professionals: How ALYZE Is Making World-Class Coordinated Health Care Available for the First Time

June 1, 2026 3:50 PM

Inside a professional sports organization, health is never managed in pieces. Every person on the medical and performance staff knows what the others have found. A training load is adjusted because the bloodwork said to. A recovery protocol is changed because the diagnostics showed it was not working. Every decision is connected to every other decision, and the system holds itself accountable for producing results. For everyone outside that...

Read more

Scientists and Policy Experts to Brief Congress on FDA's 7-OH Action, Kratom, and Consumer Protection Legislation

June 1, 2026 12:23 PM

Nearly a year after the FDA recommended in July 2025 that the DEA schedule synthetic 7-Hydroxymitragynine (7-OH) - drawing a clear line between concentrated synthetics and natural kratom plant products - there is still no federal legislation, guidance, or coherent policy to back it up, leaving state legislators confused and pursuing conflicting directives. The American Kratom Association (AKA) will host a Congressional Briefing to cut through...

Read more

Dr. Todd H. Lanman Presented Alignment-Driven Synergy Disc(R) Results and Case Experience at the 2nd Annual Hoag Orthopedic Institute Spine Symposium

June 1, 2026 11:45 AM

Todd H. Lanman, MD, FACS, FAANS, founder of Lanman Spinal Neurosurgery and ADR Spine, presented "Alignment-Driven Cervical Arthroplasty: Techniques, Case Experiences & Results with the Synergy Disc®" on Friday, May 29, at the 2nd Annual Hoag Orthopedic Institute Spine Symposium in Newport Beach, California. The presentation highlighted statistically superior 24-month outcomes from the FDA-approved Synergy Disc® 1-level IDE trial, along with...

Read more

From Fusion to Motion: Dr. Joel S. Beckett Presented Restorative Motion Surgery Concepts at the Hoag Orthopedic Institute Spine Symposium

June 1, 2026 11:40 AM

Joel S. Beckett, MD, MHS, FAANS, presented "From Fusion to Motion" on Friday, May 29th, at the 2nd Annual Hoag Orthopedic Institute Spine Symposium in Newport Beach, California. The presentation examined restorative motion surgery and the expanding role of cervical disc arthroplasty for select patients with persistent pain or pseudoarthrosis following anterior cervical discectomy and fusion (ACDF). Dr. Beckett discussed restorative motion...

Read more

IAVI to Advance Vaccine Candidate for Bundibugyo Virus, Receives Funding from CEPI

June 1, 2026 10:30 AM

IAVI, a global nonprofit biomedical research organization, today announced that it has reached an agreement with The University of Texas Medical Branch (UTMB) allowing IAVI to develop a recombinant vesicular stomatitis virus (rVSV)-based vaccine candidate targeting Bundibugyo virus (BDBV), the orthoebolavirus responsible for the ongoing Ebola epidemic in the Democratic Republic of the Congo (DRC) and Uganda. Also today, CEPI, a global...

Read more

Medical Care Technologies (OTC PINK:MDCE) Provides Initial Overview of Melanoma Scan Beta User Experience and Interface Design

June 1, 2026 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE), ("MDCE" or the "Company") a technology company focused on AI-powered imaging and wellness applications, today provided additional details regarding the user experience and interface design objectives currently being incorporated into the MDCE Melanoma Scan Beta platform. Building upon the Company's previously disclosed body-map monitoring architecture, current development efforts have...

Read more

Revelation Biosciences Expands Acute Kidney Injury Advisory Board

June 1, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced the expansion of its Acute Kidney Injury (AKI) Advisory Board, with the addition of two new members, Dr. Peter Pickkers and Dr. Lui Forni, ahead of its upcoming Phase 2/3 clinical trial. The distinguished panel comprises internationally recognized...

Read more

CVS Health: Helping Seniors Navigate Digital-First Health Care

June 1, 2026 9:00 AM

Originally published on CVS Health Company NewsroomKey pointsMany older adults struggle with digital health literacy, making everyday health tasks harder as digital-first care becomes more common.Seniors face real barriers to digital care, but they're eager to learn and want tools and experiences designed with them in mind.CVS Health is already taking meaningful steps to close the digital divide and make care simpler and more accessible for...

Read more

They're Calling It Hemp, Cannabis Medicine. Pesticides, Mycotoxins, Fraudulent Lab Reports? And Medicare Is Now Reimbursing It

June 1, 2026 8:25 AM

Let's start with what medicine actually is. Pesticides. Mycotoxins. Fraudulent Lab Reports. Now Covered by Medicare.Medicine is a substance manufactured under validated, documented, reproducible conditions - conditions that guarantee, to the highest scientifically achievable degree of certainty, that what is in the bottle is what the label says, that nothing else is in the bottle that shouldn't be, and that the patient receiving it is not...

Read more

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

June 1, 2026 8:00 AM

Moderna, Inc. (NASDAQ:MRNA) and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced detailed results from a planned five-year follow-up analysis of the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study evaluating intismeran autogene (mRNA-4157 or V940), an investigational mRNA-based individualized neoantigen therapy (INT), in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients...

Read more

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

June 1, 2026 8:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Rivaroxaban tablets of 2.5mg, 10mg, 15mg and 20mg for the Canadian market. Rivaroxaban is the generic equivalent of the brand name anticoagulant, Xarelto®.Rivaroxaban is a direct oral anticoagulant prescribed to treat and prevent deep vein...

Read more

Black Book to Release Highly Anticipated 2026 Vendor-Agnostic RCM KPI Results Ahead of HFMA Annual Conference 2026

June 1, 2026 7:50 AM

Black Book Research today announced the upcoming release of its 2026 Vendor-Agnostic Revenue Cycle Management Qualitative KPI Results, a new decision-support framework created for hospitals, health systems, physician enterprises, ambulatory networks, CFOs, revenue cycle executives, CIOs, procurement teams, and managed services buyers evaluating RCM platforms, functional software, automation tools, analytics solutions, and outsourced or...

Read more

Wellgistics Health Provides Mid-Year 2026 Corporate Outlook

June 1, 2026 7:40 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today provided a mid-year 2026 corporate outlook. The Company intends to focus on closing the recently announced DelivMeds AI transaction, continuing to drive quarter-over-quarter growth through its Wellgistics Pharmacy business unit, and supporting the...

Read more

Riccio Pharmacy Online Pharmacy Delivery: What Patients Should Know

June 1, 2026 7:30 AM

Healthcare is becoming more digital every year, and online pharmacy delivery services are now playing a major role in how patients manage medications and wellness products. For many people, convenience, accessibility, and reliable service are just as important as the medications themselves.Riccio Pharmacy has expanded its online pharmacy delivery services to help patients receive prescriptions, supplements, and healthcare products more easily...

Read more

Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congress

June 1, 2026 7:05 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that four abstracts highlighting rusfertide in polycythemia vera (PV) will be presented at the 2026 European Hematology Association Congress (EHA2026 Congress), taking place June 11-14, 2026, in Stockholm, Sweden. The presentations include analyses from the randomized, controlled Phase 3 VERIFY study, as well as long-term results from the Phase 2 REVIVE and THRIVE...

Read more

VOKA Takes Platinum at the TITAN Health Awards 2026

June 1, 2026 6:05 AM

VOKA, one of the leading medical visualization companies, has been named a Platinum Winner at the TITAN Health Awards 2026. The company topped the "Video, Commercial & Film - Animation" category with its video " Inside Immune System: Granulocytopoiesis Explained in 3D ". This international recognition highlights VOKA's dedication to digital innovation in healthcare through realistic 3D content. It also reinforces the company's focus on...

Read more

Who Does the Best Liposuction in Sarasota?

June 1, 2026 6:00 AM

Liposuction remains one of the most commonly discussed cosmetic surgery procedures for patients seeking to address stubborn fat in areas such as the abdomen, waist, hips, thighs, back, and arms. In Sarasota, determining who performs the best liposuction often comes down to measurable factors including surgical training, body-contouring specialization, patient outcomes, safety standards, procedural experience, and consistency in achieving...

Read more

Who Does the Best Mommy Makeover in Seattle?

June 1, 2026 6:00 AM

Interest in mommy makeover procedures continues to grow as more patients seek surgical solutions for physical changes following pregnancy and weight fluctuations. Patients researching the procedure often evaluate surgeon experience, surgical approach and recovery planning when selecting a provider for mommy makeover. In this case, plastic surgeon Dr. Javad Sajan of Allure Esthetic is frequently referenced in online searches, patient...

Read more

Med-X Secures Strategic Relationship with Main Line Brands, Franchisor of Mosquito Authority and Pest Authority, One of the Largest Pest Control Franchise Systems in North America

June 1, 2026 6:00 AM

Med-X, Inc. ("Med-X" or the "Company") (Nasdaq:MXRX), a leading innovator of all-natural pest control solutions, today announced that it has secured a strategic relationship with Mosquito Authority and Pest Authority, a leader in pest control across North America with over 500 territories spanning 39 states and Canada. Following months of rigorous field testing, Mosquito Authority and Pest Authority has selected the Nature-Cide brand as their...

Read more